• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心脏淀粉样变性:48例病例的病理分类及临床分析]

[Cardiac amyloidosis: pathological classification and clinical analysis of 48 cases].

作者信息

Yu T P, Hou J, Yang T J, Lei S, Yang M, Su Y Y, Chen Y C, Wu Y, Chen X Q

机构信息

Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China.

Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2023 Jul 8;52(7):671-677. doi: 10.3760/cma.j.cn112151-20221230-01082.

DOI:10.3760/cma.j.cn112151-20221230-01082
PMID:37408396
Abstract

To investigate the histological features and clinical manifestations in different types of cardiac amyloidosis to improve diagnostic accuracy. The histopathological features and clinical manifestations of 48 patients diagnosed with cardiac amyloidosis by Congo red stain and electron microscopy through endomyocardial biopsy were collected in West China Hospital of Sichuan University from January 2018 to December 2021. Immunohistochemical stains for immunoglobulin light chains (κ and λ) and transthyretin protein were carried out, and a review of literature was made. The patients age ranged from 42 to 79 years (mean 56 years) and the male to female ratio was 1.1 to 1.0. The positive rate of endomyocardial biopsy was 97.9% (47/48), which was significantly higher than that of the abdominal wall fat (7/17). Congo red staining and electron microscopy were positive in 97.9% (47/48) and 93.5% (43/46), respectively. Immunohistochemical stains showed 32 cases (68.1%) were light chain type (AL-CA), including 31 cases of AL-λ type and 1 case of AL-κ type; 9 cases (19.1%) were transthyretin protein type (ATTR-CA); and 6 cases (12.8%) were not classified. There was no significant difference in the deposition pattern of amyloid between different types (>0.05). Clinical data showed that ATTR-CA patients had less involvement of 2 or more organs and lower N-terminal pro-B-type natriuretic peptide (NT-proBNP) than the other type patients (<0.05). The left ventricular stroke volume and right ventricular ejection fraction of ATTR-CA patients were better than the other patients (<0.05). Follow-up data of 45 patients was obtained, and the overall mean survival time was 15.6±2.0 months. Univariate survival analysis showed that ATTR-CA patients had a better prognosis, while cardiac amyloidosis patients with higher cardiac function grade, NT-proBNP >6 000 ng/L, and troponin T >70 ng/L had a worse prognosis (<0.05). Multivariate survival analysis showed that NT-proBNP and cardiac function grade were independent prognostic factors for cardiac amyloidosis patients. AL-λ is the most common type of cardiac amyloidosis in this group. Congo red staining combined with electron microscopy can significantly improve the diagnosis of cardiac amyloidosis. The clinical manifestations and prognosis of each type are different and can be classified based on immunostaining profile. However, there are still a few cases that cannot be typed; hence mass spectrometry is recommended if feasible.

摘要

为研究不同类型心脏淀粉样变性的组织学特征和临床表现,以提高诊断准确性。收集了2018年1月至2021年12月在四川大学华西医院经心内膜心肌活检,通过刚果红染色和电子显微镜确诊为心脏淀粉样变性的48例患者的组织病理学特征和临床表现。进行了免疫球蛋白轻链(κ和λ)及转甲状腺素蛋白的免疫组织化学染色,并进行了文献复习。患者年龄在42至79岁之间(平均56岁),男女比例为1.1比1.0。心内膜心肌活检的阳性率为97.9%(47/48),显著高于腹壁脂肪活检的阳性率(7/17)。刚果红染色和电子显微镜检查的阳性率分别为97.9%(47/48)和93.5%(43/46)。免疫组织化学染色显示,32例(68.1%)为轻链型(AL-CA),其中包括31例AL-λ型和1例AL-κ型;9例(19.1%)为转甲状腺素蛋白型(ATTR-CA);6例(12.8%)未分类。不同类型之间淀粉样蛋白的沉积模式无显著差异(>0.05)。临床资料显示,ATTR-CA患者累及两个或更多器官的情况较少,且N末端B型利钠肽原(NT-proBNP)低于其他类型患者(<0.05)。ATTR-CA患者的左心室每搏输出量和右心室射血分数优于其他患者(<0.05)。获得了45例患者的随访数据,总体平均生存时间为15.6±2.0个月。单因素生存分析显示,ATTR-CA患者预后较好,而心功能分级较高、NT-proBNP>6000 ng/L和肌钙蛋白T>70 ng/L的心脏淀粉样变性患者预后较差(<0.05)。多因素生存分析显示,NT-proBNP和心功能分级是心脏淀粉样变性患者的独立预后因素。AL-λ是该组中最常见的心脏淀粉样变性类型。刚果红染色联合电子显微镜检查可显著提高心脏淀粉样变性的诊断率。各类型的临床表现和预后不同,可根据免疫染色结果进行分类。然而,仍有少数病例无法分型;因此,可行时建议进行质谱分析。

相似文献

1
[Cardiac amyloidosis: pathological classification and clinical analysis of 48 cases].[心脏淀粉样变性:48例病例的病理分类及临床分析]
Zhonghua Bing Li Xue Za Zhi. 2023 Jul 8;52(7):671-677. doi: 10.3760/cma.j.cn112151-20221230-01082.
2
Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.二维斑点追踪超声心动图对左心室射血分数保留型轻链型淀粉样变性患者预后的评估:对现行预后分期系统的补充价值。
JACC Cardiovasc Imaging. 2017 Apr;10(4):398-407. doi: 10.1016/j.jcmg.2016.04.008. Epub 2016 Sep 14.
3
[Classification of cardiac amyloidosis: an immunohistochemical analysis].[心脏淀粉样变性的分类:免疫组织化学分析]
Zhonghua Bing Li Xue Za Zhi. 2018 Feb 8;47(2):105-109. doi: 10.3760/cma.j.issn.0529-5807.2018.02.005.
4
Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.转甲状腺素蛋白和 AL 型心脏淀粉样变性预后标志物的鉴定。
Amyloid. 2016 Sep;23(3):194-202. doi: 10.1080/13506129.2016.1221815. Epub 2016 Sep 20.
5
Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.轻链或转甲状腺素蛋白心脏淀粉样变患者心房颤动的临床特征和预测因素。
ESC Heart Fail. 2022 Jun;9(3):1740-1748. doi: 10.1002/ehf2.13851. Epub 2022 Feb 17.
6
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.野生型转甲状腺素蛋白心脏淀粉样变在老年人群中并不罕见:CATCH 筛查研究。
Eur J Prev Cardiol. 2024 Aug 22;31(11):1410-1417. doi: 10.1093/eurjpc/zwae093.
7
Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms.心脏淀粉样变不是一种单一的疾病:轻链和转甲状腺素形式之间的多参数比较。
ESC Heart Fail. 2024 Oct;11(5):2825-2834. doi: 10.1002/ehf2.14852. Epub 2024 May 16.
8
Myocardial Edema and Prognosis in Amyloidosis.心肌水肿与淀粉样变的预后。
J Am Coll Cardiol. 2018 Jun 26;71(25):2919-2931. doi: 10.1016/j.jacc.2018.03.536.
9
Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.使用血清视黄醇结合蛋白 4 和临床预测模型鉴定转甲状腺素蛋白心脏淀粉样变性。
JAMA Cardiol. 2017 Mar 1;2(3):305-313. doi: 10.1001/jamacardio.2016.5864.
10
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure.患有心脏淀粉样变性的患者比非淀粉样变性心力衰竭患者的神经激素激活更为明显。
Amyloid. 2021 Dec;28(4):252-258. doi: 10.1080/13506129.2021.1966624. Epub 2021 Aug 16.